Add to ORKGBreast cancer is the leading cause of death by cancer among women and there is an urgent need to improve its diagnosis and prognosis. MicroRNAs (miRNAs) are non-coding RNAs that regulate gene expression and many have been implicated in breast cancer. In this article, we focus on circulating miRNAs as biomarkers for breast cancers and we describe the deregulation of their expression during neoadjuvant chemotherapy (NAC).Circulating microRNAs as diagnostic, prognostic and predictive markers in breast cancer patient
Breast cancer is considered as a heterogeneous disease comprising various types of neoplasms, which ...
Breast cancer (BC) is the most common malignancy in women. Due to BC heterogeneity, complexity, and ...
BackgroundMicroRNAs (miRNAs) have been recently detected in the circulation of cancer patients, wher...
Circulating microRNAs (miRNAs) are extensively studied in cancer as biomarkers but little is known a...
Breast cancer is the most frequently diagnosed malignancy amongst females worldwide. In recent years...
Breast cancer is the leading cause of cancer death in women worldwide. Gene expression studies have ...
Neoadjuvant chemotherapy (NACT) is used in locally advanced breast cancer to reduce tumour burden pr...
Regardless of advances in detection and treatment, breast cancer affects about 1.5 million women all...
Background: Neoadjuvant chemotherapy (NACT) is an increasingly used approach for treatment of breast...
MicroRNAs (miRNA) are small noncoding RNAs that can act as both oncogene and tumor suppressors. Dere...
MicroRNAs (miRNAs) are an emerging class of gene expression modulators with relevant roles in severa...
Circulating microRNAs (miRNAs) have been extensively studied in cancer as biomarkers but little is ...
Understanding of the molecular complexity underlying breast cancer has greatly advanced in recent ye...
Breast cancer causes severe mental stress on the affected woman during investigation, diagnosis and ...
Purpose: Prescribing NAC for breast cancer is a pragmatic treatment strategy for several reasons; ho...
Breast cancer is considered as a heterogeneous disease comprising various types of neoplasms, which ...
Breast cancer (BC) is the most common malignancy in women. Due to BC heterogeneity, complexity, and ...
BackgroundMicroRNAs (miRNAs) have been recently detected in the circulation of cancer patients, wher...
Circulating microRNAs (miRNAs) are extensively studied in cancer as biomarkers but little is known a...
Breast cancer is the most frequently diagnosed malignancy amongst females worldwide. In recent years...
Breast cancer is the leading cause of cancer death in women worldwide. Gene expression studies have ...
Neoadjuvant chemotherapy (NACT) is used in locally advanced breast cancer to reduce tumour burden pr...
Regardless of advances in detection and treatment, breast cancer affects about 1.5 million women all...
Background: Neoadjuvant chemotherapy (NACT) is an increasingly used approach for treatment of breast...
MicroRNAs (miRNA) are small noncoding RNAs that can act as both oncogene and tumor suppressors. Dere...
MicroRNAs (miRNAs) are an emerging class of gene expression modulators with relevant roles in severa...
Circulating microRNAs (miRNAs) have been extensively studied in cancer as biomarkers but little is ...
Understanding of the molecular complexity underlying breast cancer has greatly advanced in recent ye...
Breast cancer causes severe mental stress on the affected woman during investigation, diagnosis and ...
Purpose: Prescribing NAC for breast cancer is a pragmatic treatment strategy for several reasons; ho...
Breast cancer is considered as a heterogeneous disease comprising various types of neoplasms, which ...
Breast cancer (BC) is the most common malignancy in women. Due to BC heterogeneity, complexity, and ...
BackgroundMicroRNAs (miRNAs) have been recently detected in the circulation of cancer patients, wher...